Therapeuticsmd Stock News

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading womens healthcare company, today announced the settlement of the previously disclosed U.S. patent litigation for BIJUVA® with Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals, LLC, and Amneal Pharmaceuticals of New York LLC (collectively Amneal). As part of the settlement, TherapeuticsMD granted to Amneal a license to commercialize Amneals generic version of BIJUVA (1 mg estradiol and 100 mg p

TherapeuticsMD Inc (NASDAQ: TXMD) has settled the previously disclosed U.S. patent litigation for Bijuva with Amneal Pharmaceuticals Inc (NYSE: AMRX). Bijuva is a prescription medicine used to tr

TherapeuticsMD, Inc. (TXMD) with the stream of -7.54% also noticed, India RISE Education Cayman Ltd (REDU) encountered a rapid change of -9.57% in the last hour of Fridays trading session. The post This Stock is in a moonbeam: TherapeuticsMD, Inc. (NASDAQ:TXMD), RISE Education Cayman Ltd (NASDAQ:REDU) appeared first on Stocks Equity .

Metropolitan Life Insurance Co NY boosted its stake in shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) by 293,104.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 120,214 shares of the companys stock after acquiring an additional 120,173 shares during the quarter. Metropolitan Life Insurance Co []

TherapeuticsMD Inc. (NASDAQ:TXMD) traded at $0.57 at close of the session on Monday, 11/29/21, made a downward move of -1.54% on its previous days price. Looking at the stock we see that its previous close was $0.58 and the beta (5Y monthly) reads 1.92 with the days price range being $0.553 $0.5797. In terms TherapeuticsMD Inc. (NASDAQ: TXMD) Continues To Be Hot This Week? Read More »

During the recent session, TherapeuticsMD Inc. (NASDAQ:TXMD)’s traded shares were 0.88 million, with the beta value of the company hitting 1.76. At the last check today, the stock’s price was $0.57, reflecting an intraday loss of -5.33% or -$0.03. The 52-week high for the TXMD share is $2.75, that puts it down -382.46 from that … Can You Get A Quick Recovery From TherapeuticsMD Inc. (NASDAQ: TXMD) Given A -382.46% drop From High? Read More »

Wall Street brokerages expect that TherapeuticsMD, Inc. (NASDAQ:TXMD) will announce $29.26 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for TherapeuticsMDs earnings, with the highest sales estimate coming in at $30.07 million and the lowest estimate coming in at $28.46 million. TherapeuticsMD posted sales of $22.58 []

Virtu Financial LLC lessened its holdings in TherapeuticsMD, Inc. (NASDAQ:TXMD) by 79.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 88,077 shares of the companys stock after selling 343,169 shares during the quarter. Virtu Financial LLCs holdings in TherapeuticsMD were worth $105,000 as []

TherapeuticsMD, Inc. (NASDAQ:TXMD) Director Cooper C. Collins bought 1,000,000 shares of the company’s stock in a transaction that occurred on Thursday, November 18th. The shares were acquired at an average price of $0.58 per share, for a total transaction of $580,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, […]

Charles Schwab Investment Management Inc. grew its holdings in TherapeuticsMD, Inc. (NASDAQ:TXMD) by 4.2% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,488,953 shares of the companys stock after buying an additional 99,443 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately []

TherapeuticsMD, Inc. (NASDAQ:TXMD) Director Cooper C. Collins bought 1,000,000 shares of TherapeuticsMD stock in a transaction that occurred on Thursday, November 18th. The stock was bought at an average cost of $0.58 per share, for a total transaction of $580,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at []

In todays recent session, 2.85 million shares of the TherapeuticsMD Inc. (NASDAQ:TXMD) have been traded, and its beta is 1.76. Most recently the companys share price was $0.59, and it changed around $0.02 or 4.05% from the last close, which brings the market valuation of the company to $248.29M. TXMD at last check was trading TherapeuticsMD Inc. (NASDAQ: TXMD): A Stock Worth Thinking About Today Read More »

The trading price of TherapeuticsMD Inc. (NASDAQ:TXMD) closed lower on Friday, November 19, closing at $0.57, -2.71% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

TherapeuticsMD, Inc. (TXMD) with the stream of -2.71% also noticed, India Truist Financial Corporation (TFC) encountered a rapid change of -1.99% in the last hour of Friday’s trading session. TherapeuticsMD, … The post Nano Dimension Ltd., NASDAQ:NNDM, NNDM NEWS, NNDM STOCK, Teck Resources Limited, NYSE:TECK, TECK NEWS, TECK STOCK, NNDM, TECK appeared first on Stocks Equity .

TherapeuticsMD Inc. (NASDAQ:TXMD)s traded shares stood at 5.76 million during the last session, with the companys beta value hitting 1.78. At the close of trading, the stocks price was $0.57, to imply a decrease of -2.30% or -$0.02 in intraday trading. The TXMD shares 52-week high remains $2.75, putting it -382.46% down since that peak TherapeuticsMD Inc. (NASDAQ:TXMD) Down -1.75% Since 52-Week Low; YTD Fall -52.52% Heres What You Need To Do Read More »